3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase 1/2
6
Phase 1
6
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Ovarian Neoplasms
2
Neuroblastoma
2
Endometrial Neoplasms
2
Turcot syndrome
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rhabdoid Tumor
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Medulloblastoma
1
Lymphoma, B-Cell
1
Head and Neck Neoplasms
1
Glioma
1
Fallopian Tube Neoplasms
1
EGFR Positive Non-small Cell Lung Cancer
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
7
Temozolomide
6
Radiotherapy
6
fluciclovine F-18
4
Topotecan
4
fluorodopa F 18
3
Biopsy
3
niraparib
2
abemaciclib
2
Standard of Care
2
Specimen Handling
2
Pemetrexed
2
Ketoconazole
2
ulixertinib
1
temsirolimus
1
ribociclib
1
posaconazole
1
poly ICLC
1
pitavastatin
1
pembrolizumab
1
orludodstat
1
lorlatinib
1
larotrectinib
1
infigratinib
1
fisetin
1
fimepinostat
1
evolocumab
1
clevudine
1
X-Rays
1
Watchful Waiting
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Glioma
×
Carboplatin
×
Clear all
NCT02279992
2017-09-11
LevitraCarbo
Cedars-Sinai Medical Center
Phase EARLY_PHASE1
Terminated
7 enrolled